Antisense oligonucleotides directed against ribonucleotide...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01)

Patent

CA 2535650

The present invention provides antisense oligonucleotides directed to a mammalian ribonucleotide reductase R2 gene and combinations of the antisense oligonucleotides with one or more chemotherapeutic agents for use in the treatment of cancer.

L'invention porte: sur des oligonucléotides antisens se dirigeant vers le gène de ribonucléotide réductase R2 de mammifère, et sur leur combinaison, avec un ou plusieurs agents de chimiothérapie, utilisée pour le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense oligonucleotides directed against ribonucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotides directed against ribonucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides directed against ribonucleotide... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2049802

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.